Gene · 10728
Papers1,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sec62 restricts ER-replicating positive-strand RNA virus infections via UPR-dependent ER-phagy. | Plant Cell | 2026 | 41592053 | PubTator, text mining | PubMed |
| Analysis of genetic variability in grapevine leafroll-associated virus 13 and the characteristics of the p23. | Plant Physiol Biochem | 2026 | 41429104 | PubTator, text mining | PubMed |
| The possibilities and challenges associated with selective targeting Plasmodium falciparum Hsp90 for Malaria. | Trans R Soc S Afr | 2025 | 41836916 | PubTator, text mining | PubMed |
| Screening telomere-related genes to predict prognosis, immunotherapy response, and drug sensitivity in esophageal cancer using a machine learning approach. | J Cardiothorac Surg | 2025 | 41340128 | PubTator, text mining | PubMed |
| Plasma proteomics profiling identifies predictive biomarkers for immunotherapy response in small-cell lung cancer. | Lung Cancer | 2025 | 41197383 | PubTator, text mining | PubMed |
| Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer. | Nat Genet | 2025 | 41193657 | PubTator, text mining | PubMed |
| Systemic immune activity occurs during human immune system maturation. | Cell | 2025 | 41161316 | PubTator, text mining | PubMed |
| Machine learning integration with multi-omics data constructs a robust prognostic model and identifies PTGES3 as a therapeutic target for precision oncology in lung adenocarcinoma. | Front Immunol | 2025 | 41089696 | PubTator, text mining | PubMed |
| P23 acts as a negative regulator of ferroptosis in NSCLC by blocking GPX4 degradation via chaperone-mediated autophagy. | Mol Cancer | 2025 | 41039570 | PubTator, text mining | PubMed |
| SP1 and p23 play a crucial role in the circadian target gene induction of activated aryl hydrocarbon receptor in human breast cells. | Cell Biol Toxicol | 2025 | 40936027 | PubTator, text mining | PubMed |
| Programmable translational inhibition by a molecular glue-oligonucleotide conjugate. | bioRxiv | 2025 | 40791481 | PubTator, text mining | PubMed |
| Complete Sequence Analysis of Grapevine Leafroll-Associated Virus 4 and Interactions Between the Encoded Proteins. | Viruses | 2025 | 40733569 | PubTator, text mining | PubMed |
| Progress in Our Understanding of the Cross-Protection Mechanism of CTV-VT No-SY Isolates Against Homologous SY Isolates. | Pathogens | 2025 | 40732747 | PubTator, text mining | PubMed |
| Upregulation of 15-Hydroxyprostaglandin Dehydrogenase by Celecoxib to Reduce Pain After Laparoendoscopic Single-Site Surgery (POPCORN Trial): A Randomized Controlled Trial. | Biomedicines | 2025 | 40722854 | PubTator, text mining | PubMed |
| Oropouche virus infection induces pyroptosis in human THP-1 macrophages. | Virology | 2025 | 40712304 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis and m6A-Target gene signatures for diagnostic significance and immune microenvironment characterization in polycystic ovary syndrome. | Sci Rep | 2025 | 40481029 | PubTator, text mining | PubMed |
| Publisher Correction: Tick salivary proteins metalloprotease and allergen-like p23 are associated with response to glycan α-Gal and mycobacterium infection. | Sci Rep | 2025 | 40467638 | PubTator, text mining | PubMed |
| Archaeometric Analyses of Medieval Pottery from the Lower Danube Region, Romania. | Chempluschem | 2025 | 40464701 | PubTator, text mining | PubMed |
| CO-CHAPERONE P23 INHIBITS FERROPTOSIS IN SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY BY REGULATING GPX4 STABILITY. | Shock | 2025 | 40333430 | PubTator, text mining | PubMed |
| Integrating bulk, single-cell, and spatial transcriptomics to identify and functionally validate novel targets to enhance immunotherapy in NSCLC. | NPJ Precis Oncol | 2025 | 40240582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10728/papers?page=2